Nanoplastics have quietly crossed an important threshold. They are no longer confined to environmental monitoring reports or ecological risk assessments. They are increasingly being documented within biological systems. Yet despite the growing volume of evidence, the field still lacks a coherent explanation for how exposure translates into long-term biological consequence.

The problem is not a shortage of observations. It is a shortage of integration.

Research on gut–organ communication has reinforced the importance of barrier integrity as a determinant of systemic physiology rather than a simple anatomical function (Nie et al., 2024). Reports describing microplastics and nanoplastics in neural contexts have expanded concern beyond exposure itself toward questions of developmental and neurological vulnerability (Ragusa & Fanos, 2025). Simultaneously, advances in artificial intelligence are improving the detection and characterization of plastic contamination across increasingly complex environmental and food matrices (Rawat et al., 2025).

These developments are significant. They are not, however, sufficient.

Exposure can be measured. Distribution can be mapped. Individual mechanisms can be described. What remains unresolved is the biological logic connecting these observations across scales. How does a molecular interaction become a systems disturbance? At what point does a localized adaptive response evolve into persistent physiological dysfunction? Existing toxicological frameworks provide important pieces of the puzzle, yet they rarely explain how these pieces fit together.

The present work addresses this gap through a systems-oriented perspective. It advances the proposition that nanoplastic-associated biological effects may be better understood not as isolated toxicological events but as interconnected processes operating across proteostatic regulation, inflammatory signaling, and metabolic adaptation. Within this context, the Nanoplastic Proteostatic Panflemmosis Metabolic Continuum (NPPMC) is introduced as a conceptual architecture linking nanoplastic identity transformation, proteostatic disruption, chronic inflammatory propagation, and metabolic reprogramming within a unified biological trajectory.

This perspective further builds upon emerging work in Digital Nano-Plastic Science (DNPS) (Reyed, 2026b), Polybiome Systems Medicine (Reyed, 2026c), neuroinflammatory and autophagic regulation (Reyed & Prabhakar, 2026a), and panflemmotic mechanisms associated with chronic disease progression and tumorigenesis (Reyed & Prabhakar, 2026b). The objective is not to claim a definitive mechanism. It is to establish a framework through which increasingly fragmented observations can be interpreted, challenged, and tested within a broader systems-biology context.

As evidence continues to accumulate across environmental, clinical, and computational domains, the central challenge may no longer be detecting nanoplastic exposure. The greater challenge is understanding its place within the architecture of biological dysfunction.

Key References Supporting the Framework:

Nie, H. Y., Ge, J., Huang, G. X., Liu, K. G., Yue, Y., Li, H., Lin, H. G., Zhang, T., Yan, H. F., Xu, B. X., Sun, H. W., Yang, J. W., Si, S. Y., Zhou, J. L., & Cui, Y. (2024). New insights into the intestinal barrier through “gut-organ” axes and a glimpse of microgravity’s effects on intestinal barrier. Frontiers in Physiology, 15, 1465649. https://doi.org/10.3389/fphys.2024.1465649

Ragusa, A., & Fanos, V. (2025). Microplastics and nanoplastics in the brain: a review of the neurodevelopmental risks. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), 14(2), e140206. https://doi.org/10.7363/140206

Rawat, H., Gaur, A., Singh, N., Selvaraj, M., Karnwal, A., Pant, G., & Malik, T. (2025). Artificial intelligence-driven detection of microplastics in food: A comprehensive review of sources, health risks, detection techniques, and emerging artificial intelligence solutions. Food Chemistry: X, 29, 102687. https://doi.org/10.1016/j.fochx.2025.102687

Reyed, R. M. (2026b). Digital Nano-Plastic Science (DNPS) paradigm: Computational intelligence and proteostasis disruptions. Zenodo. https://doi.org/10.5281/zenodo.18435353

Reyed, R. M. (2026c). Polybiome systems medicine: Conceptual architecture, methodological foundations, and translational applications — Volume I: Vision and foundational methodology (Version 0.2). Zenodo. https://doi.org/10.5281/zenodo.19258533

Reyed, R. M., & Prabhakar, P. K. (2026a). Modulating neuroinflammation and autophagy in psychiatric disorders through mechanisms and therapies: Therapeutic strategies and pathways. In T. Mokhtari & K. Uludag (Eds.), Autophagy and inflammation in neuropsychological disorders (pp. 61–124). IGI Global Scientific Publishing. https://doi.org/10.4018/979-8-3693-5908-2.ch003

Reyed, R. M., & Prabhakar, P. K. (2026b). Chapter 8 - Panflemmotic triggers to metastatic pathways: Complex signatures of tumorigenesis in the colonic microenvironment. In A. Kumar, N. Mishra, A. K. Singh, A. Pareek, & P. K. Prabhakar (Eds.), Inflammation and cancer (pp. 247–346). Academic Press. https://doi.org/10.1016/B978-0-443-36500-3.00008-